|
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RECRUITINGPhase 3Sponsored by Amgen
Actively Recruiting
PhasePhase 3
SponsorAmgen
Started2025-08-22
Est. completion2031-10-20
Eligibility
Age50 Years – 105 Years
Healthy vol.Accepted
Locations203 sites
View on ClinicalTrials.gov →
NCT07136012
Summary
The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardial infarction, or urgent coronary revascularization in participants at risk for a first major cardiovascular event with elevated lipoprotein(a) (Lp\[a\]).
Eligibility
Age: 50 Years – 105 YearsHealthy volunteers accepted
Inclusion Criteria: * Age ≥50 years * Lp(a)≥ 200 nmol/L during screening * Multiple atherosclerotic cardiovascular disease risk factors, and/or evidence of atherosclerosis Exclusion Criteria: * Prior acute atherothrombotic event (myocardial infarction, stroke, transient ischemic attack, acute limb ischemia) * Prior or planned arterial revascularization * History of major bleeding disorder
Conditions2
Cardiovascular DiseaseHeart Disease
Interventions1
Locations203 sites
Advanced Cardiovascular LLC
Alexander City, Alabama, 35010
University of Alabama Birmingham Saint Vincents Birmingham
Birmingham, Alabama, 35205
Birmingham Clinical Research
Birmingham, Alabama, 35209
Alliance For Multispecialty Research - Daphne
Daphne, Alabama, 36526
Eastern Shore Research Institute
Fairhope, Alabama, 36532
Find trials near these locations
Heart Disease trials in PhoenixHeart Disease trials in TucsonHeart Disease trials in Los AngelesHeart Disease trials in San DiegoHeart Disease trials in Colorado SpringsHeart Disease trials in JacksonvilleHeart Disease trials in MiamiHeart Disease trials in AtlantaHeart Disease trials in IndianapolisHeart Disease trials in BaltimoreHeart Disease trials in BostonHeart Disease trials in MinneapolisAll trials in ArizonaAll trials in CaliforniaAll trials in ColoradoAll trials in FloridaAll trials in GeorgiaAll trials in IllinoisAll trials in IndianaAll trials in KentuckyAll trials in LouisianaAll trials in MarylandAll trials in MassachusettsAll trials in MinnesotaAll trials in MissouriAll trials in NebraskaAll trials in NevadaAll trials in New YorkAll trials in North CarolinaAll trials in OhioAll trials in OklahomaAll trials in PennsylvaniaAll trials in TennesseeAll trials in TexasAll trials in VirginiaAll trials in Washington
Related trials
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 3
SponsorAmgen
Started2025-08-22
Est. completion2031-10-20
Eligibility
Age50 Years – 105 Years
Healthy vol.Accepted
Locations203 sites
View on ClinicalTrials.gov →
NCT07136012